425: Runway to Acquire SWK Holdings, Boosts Healthcare Focus

Runway Growth Finance Corp. announces a definitive merger agreement to acquire SWK Holdings, significantly expanding its healthcare and life sciences portfolio.

Summary

• Runway Growth Finance Corp. (RWAY) has entered into a definitive merger agreement to acquire SWK Holdings Corporation (SWK Holdings).
• The transaction is structured as a NAV-for-NAV merger, a tax-free reorganization, with an estimated purchase price of approximately $220 million.
• Consideration for the merger includes $75.5 million in Runway shares, valued at closing NAV per share, and approximately $145 million in cash.
• The acquisition will immediately increase Runway's portfolio by approximately $242 million, based on the estimated fair value of SWK's portfolio as of August 15, 2025.
• This merger will increase Runway's exposure to the healthcare and life sciences sector from 14% to approximately 31% of its overall portfolio.
• The combined entity is projected to have $1.3 billion in total assets on a pro forma basis.
• The transaction is expected to close at the end of 2025 or early in the first quarter of 2026, subject to shareholder and regulatory approvals and other customary closing conditions.

Sentiment

Score: 9

Explanation: The filing presents a highly positive outlook on the merger, emphasizing significant strategic benefits, financial enhancements, and growth opportunities. Management's tone is confident and optimistic about the immediate and long-term impacts.

Positives

• Immediate increase in portfolio size by approximately $242 million, based on SWK's estimated fair value as of August 15, 2025.
• Significant expansion into the attractive healthcare and life sciences sector, increasing its portfolio percentage from 14% to approximately 31%.
• Optimizes the portfolio through diversification and scale, leading to a pro forma balance sheet of $1.3 billion in total assets.
• Improved risk profile with smaller average loan positions, expected to be 2% of the portfolio.
• Enhanced earnings power, anticipating mid-single digit run-rate Net Investment Income (NII) accretion during the first full quarter post-close.
• Supports modest Return on Equity (ROE) expansion and improved dividend coverage.
• Optimized leverage profile of 1.1x, placing the combined company in the middle of its target range.
• Greater expense efficiency as a result of increased scale.
• Broadens the shareholder base and trading liquidity of common shares through the issuance of $75.5 million in Runway shares to SWK stockholders.
• Positions Runway as a serious participant in the consolidation of venture and growth lending markets, bolstered by the support of the BC Partners Credit platform.
• Gains SWK's team with over 20 years of investing experience in healthcare and life sciences.
• Increases capacity to issue larger checks, within Runway's target investment range of $20 million to $45 million, to high-quality names.

Risks

• Uncertainties associated with the ability of the parties to consummate the merger on the expected timeline, or at all.
• Risks that the expected synergies and savings associated with the merger may not be fully realized.
• The ability to realize the anticipated benefits of the merger, including the expected elimination of certain expenses and costs.
• The impact of the merger on the depth of trading in Runway's shares of common stock post-closing.
• The possibility that any or all of the various conditions to the consummation of the merger may not be satisfied or waived.
• Risks related to diverting management's attention from ongoing business operations.
• The potential termination of the merger agreement.
• Uncertainty regarding the future operating results and net investment income projections of the combined company.
• The ability of Runway Growth Capital LLC to implement its future plans with respect to the combined company.
• The ability of Runway Growth Capital LLC and its affiliates to attract and retain highly talented professionals.
• The business prospects of the combined company and the prospects of its portfolio companies.
• The expected financings and investments and additional leverage that the combined company may seek to incur in the future.
• The adequacy of the cash resources and working capital of the combined company.
• The risk that stockholder litigation in connection with the merger may result in significant costs of defense and liability.
• Forward-looking statements are not a guarantee of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially.

Future Outlook

The combined company anticipates enhanced earnings power, including mid-single digit run-rate NII accretion and modest ROE expansion, supported by a larger, more diversified portfolio and optimized leverage. Runway aims to continue organic and inorganic growth, leveraging the BC Partners Credit platform and positioning itself as a leader in venture and growth lending consolidation.

Management Comments

• David Spreng (CEO, Runway): "Runway has entered into a definitive merger agreement to acquire SWK Holdings, a specialty finance company with a focus on healthcare and life sciences."
• David Spreng (CEO, Runway): "Runway's acquisition of SWK will immediately increase our portfolio by approximately $242 million... The addition of this portfolio will also serve to increase immediately our exposure to healthcare and life sciences."
• Jody Staggs (President & CEO, SWK): "SWK is a specialty finance company focused on the healthcare and life science industries. We provide minimally dilutive financing to smalland mid-sized commercial-stage life science companies."
• Jody Staggs (President & CEO, SWK): "Through this merger, shareholders will benefit from the robust platform that Runway and BC Partners Credit have built. The combined entity will have increased capacity to issue larger checks to high quality names in SWK's core competencies."
• Greg Greifeld (CIO, Runway Growth Capital): "This transaction expands Runway's position and investment capabilities in the healthcare and life sciences sector... this percentage will increase to approximately 31% of the portfolio."
• Greg Greifeld (CIO, Runway Growth Capital): "This transaction drives Runway's portfolio scale and diversification through a high quality, complementary portfolio. The transaction will expand Runway's balance sheet to $1.3 billion in total assets on a pro forma basis."
• Tom Raterman (CFO & COO, Runway): "This transaction enhances our financial profile and grows our shareholder base... We anticipate enhanced earnings power supported by... mid-single digit run-rate NII accretion during the first full quarter following the transaction close."
• Tom Raterman (CFO & COO, Runway): "Runway is broadening its shareholder base and trading liquidity of its common shares through the merger terms, which include $75.5 million in Runway shares to be issued to SWK's stockholders."

Industry Context

The merger is presented as a strategic move within an intensifying competitive landscape in private markets, particularly in venture and growth lending. It positions Runway to participate in industry consolidation, leveraging the support of the BC Partners Credit platform. The increased focus on healthcare and life sciences aligns with a belief in its compelling opportunities, high barriers to entry, and strong risk-adjusted returns.

Stakeholder Impact

• Shareholders (Runway): Expected to benefit from increased portfolio scale, diversification, enhanced earnings power (NII accretion, ROE expansion, dividend coverage), improved trading liquidity, and a broader shareholder base.
• Shareholders (SWK): Will receive consideration in Runway shares and cash, benefiting from the robust platform of Runway and BC Partners Credit.
• Employees (SWK): The SWK team is expected to work with the Runway team, implying integration and continued roles within the combined entity.
• Investment Professionals: The combined entity will have increased capacity to issue larger checks, potentially benefiting companies seeking financing in the healthcare and life sciences sectors.

Next Steps

• Closing of the merger at the end of 2025 or early Q1 2026, pending shareholder and regulatory approvals.
• Runway to update on third-quarter financial results in November.
• Filing of a Combined Proxy Statement and Prospectus with the SEC.

Key Dates

Recommendation

The acquisition of SWK Holdings is a highly strategic and financially accretive move for Runway Growth Finance. It significantly expands Runway's presence in the high-growth, high-barrier-to-entry healthcare and life sciences sector, diversifying its portfolio and enhancing its risk profile. The anticipated mid-single digit NII accretion, modest ROE expansion, and improved dividend coverage, combined with an optimized leverage profile and increased scale, suggest a strong positive impact on shareholder value. The transaction also positions Runway favorably for future growth and industry consolidation, supported by the BC Partners Credit platform. The issuance of shares to SWK stockholders is expected to improve trading liquidity, which is a positive for a publicly listed BDC. While risks associated with merger integration exist, the overall strategic rationale and projected financial benefits make this a compelling investment opportunity.

Keywords

Merger, Acquisition, Healthcare Finance, Life Sciences, Specialty Finance, BDC, Venture Lending, Growth Lending, Runway Growth Finance, SWK Holdings, Portfolio Diversification, NII Accretion, BC Partners Credit